318 related articles for article (PubMed ID: 27546233)
1. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.
Martin RC; Durham AN; Besselink MG; Iannitti D; Weiss MJ; Wolfgang CL; Huang KW
J Surg Oncol; 2016 Dec; 114(7):865-871. PubMed ID: 27546233
[TBL] [Abstract][Full Text] [Related]
2. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
3. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
4. Stage III pancreatic cancer and the role of irreversible electroporation.
Al Efishat M; Wolfgang CL; Weiss MJ
BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
[TBL] [Abstract][Full Text] [Related]
5. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
Kwon D; McFarland K; Velanovich V; Martin RC
Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
[TBL] [Abstract][Full Text] [Related]
6. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation of locally advanced pancreatic head adenocarcinoma.
Martin RC
J Gastrointest Surg; 2013 Oct; 17(10):1850-6. PubMed ID: 23929188
[TBL] [Abstract][Full Text] [Related]
8. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report.
Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR
Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173
[TBL] [Abstract][Full Text] [Related]
11. [Irreversible electroporation in the treatment of locally advanced pancreatic cancer].
Záruba P; Hoskovec D; Lacman J; Hořejš J; Krška Z; Ryska M
Rozhl Chir; 2015 Dec; 94(12):504-9. PubMed ID: 26767900
[TBL] [Abstract][Full Text] [Related]
12. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
13. Irreversible Electroporation for Locally Advanced Pancreatic Cancer: Where Do We Stand in 2017?
Tasu JP; Vesselle G; Herpe G; Richer JP; Boucecbi S; Vélasco S; Debeane B; Carretier M; Tougeron D
Pancreas; 2017 Mar; 46(3):283-287. PubMed ID: 28187107
[TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
Martin RC; McFarland K; Ellis S; Velanovich V
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
[TBL] [Abstract][Full Text] [Related]
15. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
17. Early nontumorous CT findings after irreversible electroporation of locally advanced pancreatic cancer.
Schulz B; Ou J; Van Meter T; Martin RC
Abdom Radiol (NY); 2016 Nov; 41(11):2142-2149. PubMed ID: 27351439
[TBL] [Abstract][Full Text] [Related]
18. A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma.
O'Neill C; Hayat T; Hamm J; Healey M; Zheng Q; Li Y; Martin RCG
Surgery; 2020 Oct; 168(4):610-616. PubMed ID: 32631655
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE).
Martin RC; Agle S; Schlegel M; Hayat T; Scoggins CR; McMasters KM; Philips P
Eur J Surg Oncol; 2017 Apr; 43(4):772-779. PubMed ID: 28162818
[TBL] [Abstract][Full Text] [Related]
20. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
de Liguori Carino N; O'Reilly DA; Siriwardena AK; Valle JW; Radhakrishna G; Pihlak R; McNamara MG
Eur J Surg Oncol; 2018 Oct; 44(10):1486-1493. PubMed ID: 30146253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
